Rosetta Genomics Ltd. engages in the provision of therapeutic, diagnostic product development, and medical research services. The firm is marketing and selling over four diagnostic tests based on its microRNA technologies, which include RosettaGX Cancer Origin, mi-LUNG, mi-KIDNEY, and RosettaGX Reveal. The firm's therapeutic pipeline consists of the projects, which include Rimonim Consortium and Magneton Project. The firm focuses on developing a diagnostic assay, RosettaGX Reveal V2. The company is also focusing on developing Bladder cancer risk stratification.
Follow-Up Questions
Rosetta Genomics Ltd (ROSGQ) 的本益比是多少？
Rosetta Genomics Ltd 的本益比是 0
ROSGQ 股票的價格表現如何？
ROSGQ 的當前價格為 $0.0001，在上個交易日 decreased 了 0%。
Rosetta Genomics Ltd 的主要業務主題或行業是什麼？
Rosetta Genomics Ltd 屬於 Biotechnology 行業，該板塊是 Health Care
